See more news releases in Biotechnology | Health Care & Hospitals | Medical Pharmaceuticals | Pharmaceuticals

Palatin Technologies, Inc. To Report Fiscal Year 2013 Fourth Quarter Results

Teleconference and Webcast to be held on October 1, 2013

CRANBURY, N.J., Sept. 25, 2013 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE MKT: PTN) will announce its fourth quarter, fiscal year 2013 operating results on Monday, September 30, 2013 after the close of the U.S. financial markets.

Palatin will also conduct a conference call and live audio webcast hosted by its executive management team on October 1, 2013 at 10:00 a.m. ET. The conference call will include a review on the company's operating results and an update on programs under development.

Schedule for the Operating Results Press Release, Conference Call / Webcast

Q4 & Fiscal Year 2013 Financial Results Press Release	9/30/2013 at 4:30 p.m. ET

Q4 & Fiscal Year 2013 Conference Call-Live	10/1/2013 at 10:00 a.m. ET
Domestic Dial-In Number	1-888-417-8516
International Dial-In Number	1-719-325-2429
Passcode	6711298

Q4 & Fiscal Year 2013 Conference Call-Replay	10/1/2013-10/8/2013
Domestic Dial-In Number	1-888-203-1112
International Dial-In Number	1-719-457-0820
Passcode	6711298

Webcast Live and Replay Access	http://www.palatin.com

The webcast and replay can be accessed by logging on to the "Investor/Media Center-Webcasts" section of Palatin's website at http://www.palatin.com

About Palatin Technologies, Inc.
Palatin Technologies, Inc. is a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with significant unmet medical need and commercial potential. Palatin's strategy is to develop products and then form marketing collaborations with industry leaders in order to maximize their commercial potential. For additional information, please visit http://www.palatin.com or follow us on Twitter at http://twitter.com/PalatinTech.

SOURCE Palatin Technologies, Inc.